{"id":"W2593067736","doi":"10.1158/1078-0432.ccr-16-2796","title":"A Phase I–II Study of the Oral PARP Inhibitor Rucaparib in Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Carcinoma or Other Solid Tumors","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":236,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"PARP inhibitor; Ovarian cancer; Germline; Medicine; Cancer research; Germline mutation; Ovarian carcinoma; Internal medicine; Oncology; Cancer; Mutation; Poly ADP ribose polymerase; Biology; Genetics; DNA; Polymerase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002826676,0.000264121,0.0009271092,0.0001919633,0.00056674,0.0000619327,0.0007928666,0.0001839239,0.0007598149],"category_scores_gemma":[0.001083489,0.0001515566,0.0001405919,0.0006159633,0.001349377,0.0001637186,0.0004274556,0.001501098,0.00001377856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003265453,"about_ca_system_score_gemma":0.001539914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003571556,"about_ca_topic_score_gemma":0.004057568,"domain_scores_codex":[0.9948798,0.0008385659,0.001250955,0.0007391693,0.001575267,0.0007162833],"domain_scores_gemma":[0.9959685,0.000371266,0.0005155681,0.001857298,0.0009528073,0.0003346178],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03324781,0.01495332,0.9400382,0.00007435359,0.0001693859,0.00008691428,0.001086474,0.000008601511,0.000302668,0.00001130622,0.003196799,0.006824173],"study_design_scores_gemma":[0.1008298,0.02538124,0.8667176,0.0007753988,0.00007338111,0.000003396245,0.0003978524,0.0001177936,0.002906216,0.0000631034,0.002485559,0.0002486918],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937222,0.00006553961,0.000002389287,0.002244046,0.0004094722,0.002967982,0.0001180947,0.00002445435,0.0004458282],"genre_scores_gemma":[0.9973487,0.00002209593,0.00004331351,0.0005309042,0.0005140903,0.0004556414,0.000009544421,0.00007346911,0.001002197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0733206,"threshold_uncertainty_score":0.831944,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2419675665224092,"score_gpt":0.5440788431986607,"score_spread":0.3021112766762516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}